Celularity Stock Gross Profit

CELU Stock

USD 2.76 0.09 3.16%

Celularity fundamentals help investors to digest information that contributes to Celularity's financial success or failures. It also enables traders to predict the movement of Celularity Stock. The fundamental analysis module provides a way to measure Celularity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Celularity stock.

	Last Reported	Projected for Next Year
Gross Profit	6.8 M	6.5 M
Gross Profit Margin	0.30	0.51

Gross Profit Margin is likely to gain to 0.51 in 2024, whereas Gross Profit is likely to drop slightly above 6.5 M in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Celularity Company Gross Profit Analysis

Celularity's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Gross Profit

Revenue

-

Cost of Revenue

More About Gross Profit | All Equity Analysis

Current Celularity Gross Profit

(1.69 M)

Most of Celularity's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Celularity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Celularity Gross Profit Driver Correlations

Understanding the fundamental principles of building solid financial models for Celularity is extremely important. It helps to project a fair market value of Celularity Stock properly, considering its historical fundamentals such as Gross Profit. Since Celularity's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Celularity's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Celularity's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Good Will	Capital Surpluse	Intangible Assets	Current Deferred Revenue	Deferred Long Term Liab	Net Invested Capital	Capital Stock	Net Working Capital	Short Term Debt	Short Long Term Debt
Total Assets		-0.08	0.76	0.22	-0.68	0.22	0.46	0.74	0.83	0.27	0.88	-0.09	0.79	-0.58	-0.55	-0.04	0.58	0.49	-0.32	0.28	0.04
Total Stockholder Equity	-0.08		-0.37	0.64	0.08	0.07	-0.14	-0.73	-0.53	0.42	0.0	-0.08	-0.17	0.08	-0.32	-0.08	0.34	0.31	-0.26	0.24	0.07
Net Tangible Assets	0.76	-0.37		0.28	-0.94	0.57	0.84	0.77	0.94	-0.25	0.86	-0.53	0.94	-0.9	-0.71	-0.47	0.72	0.71	-0.66	0.63	0.44
Net Debt	0.22	0.64	0.28		-0.5	0.39	0.52	-0.28	0.02	0.25	0.49	-0.63	0.35	-0.55	-0.67	-0.58	0.7	0.73	-0.84	0.86	0.55
Retained Earnings	-0.68	0.08	-0.94	-0.5		-0.75	-0.89	-0.52	-0.78	0.19	-0.9	0.72	-0.94	0.98	0.9	0.64	-0.89	-0.9	0.83	-0.79	-0.6
Accounts Payable	0.22	0.07	0.57	0.39	-0.75		0.84	0.11	0.32	-0.28	0.6	-0.78	0.7	-0.78	-0.78	-0.57	0.69	0.83	-0.71	0.65	0.47
Net Receivables	0.46	-0.14	0.84	0.52	-0.89	0.84		0.42	0.62	-0.27	0.78	-0.77	0.88	-0.91	-0.79	-0.58	0.75	0.86	-0.85	0.82	0.5
Total Liab	0.74	-0.73	0.77	-0.28	-0.52	0.11	0.42		0.93	-0.09	0.61	-0.01	0.66	-0.45	-0.16	0.02	0.17	0.13	-0.05	0.03	-0.02
Total Current Assets	0.83	-0.53	0.94	0.02	-0.78	0.32	0.62	0.93		-0.15	0.79	-0.26	0.85	-0.72	-0.49	-0.24	0.5	0.45	-0.38	0.35	0.24
Common Stock	0.27	0.42	-0.25	0.25	0.19	-0.28	-0.27	-0.09	-0.15		0.2	0.11	-0.18	0.18	0.16	0.1	-0.16	-0.16	0.14	-0.13	-0.09
Property Plant Equipment	0.88	0.0	0.86	0.49	-0.9	0.6	0.78	0.61	0.79	0.2		-0.52	0.92	-0.85	-0.78	-0.4	0.77	0.78	-0.67	0.63	0.36
Good Will	-0.09	-0.08	-0.53	-0.63	0.72	-0.78	-0.77	-0.01	-0.26	0.11	-0.52		-0.5	0.83	0.68	0.94	-0.62	-0.74	0.87	-0.86	-0.89
Capital Surpluse	0.79	-0.17	0.94	0.35	-0.94	0.7	0.88	0.66	0.85	-0.18	0.92	-0.5		-0.88	-0.82	-0.36	0.81	0.82	-0.68	0.63	0.3
Intangible Assets	-0.58	0.08	-0.9	-0.55	0.98	-0.78	-0.91	-0.45	-0.72	0.18	-0.85	0.83	-0.88		0.87	0.75	-0.85	-0.89	0.88	-0.85	-0.71
Current Deferred Revenue	-0.55	-0.32	-0.71	-0.67	0.9	-0.78	-0.79	-0.16	-0.49	0.16	-0.78	0.68	-0.82	0.87		0.58	-0.99	-0.98	0.86	-0.81	-0.54
Deferred Long Term Liab	-0.04	-0.08	-0.47	-0.58	0.64	-0.57	-0.58	0.02	-0.24	0.1	-0.4	0.94	-0.36	0.75	0.58		-0.56	-0.61	0.79	-0.8	-0.99
Net Invested Capital	0.58	0.34	0.72	0.7	-0.89	0.69	0.75	0.17	0.5	-0.16	0.77	-0.62	0.81	-0.85	-0.99	-0.56		0.97	-0.87	0.83	0.52
Capital Stock	0.49	0.31	0.71	0.73	-0.9	0.83	0.86	0.13	0.45	-0.16	0.78	-0.74	0.82	-0.89	-0.98	-0.61	0.97		-0.92	0.88	0.55
Net Working Capital	-0.32	-0.26	-0.66	-0.84	0.83	-0.71	-0.85	-0.05	-0.38	0.14	-0.67	0.87	-0.68	0.88	0.86	0.79	-0.87	-0.92		-1.0	-0.74
Short Term Debt	0.28	0.24	0.63	0.86	-0.79	0.65	0.82	0.03	0.35	-0.13	0.63	-0.86	0.63	-0.85	-0.81	-0.8	0.83	0.88	-1.0		0.76
Short Long Term Debt	0.04	0.07	0.44	0.55	-0.6	0.47	0.5	-0.02	0.24	-0.09	0.36	-0.89	0.3	-0.71	-0.54	-0.99	0.52	0.55	-0.74	0.76

Click cells to compare fundamentals

Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.

Competition

Predict Celularity

Gross Profit Over Time

According to the company disclosure, Celularity reported (1.69 Million) of gross profit. This is 100.08% lower than that of the Biotechnology sector and 100.18% lower than that of the Health Care industry. The gross profit for all United States stocks is 100.01% higher than that of the company.

Celularity Gross Profit Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Celularity's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Celularity could also be used in its relative valuation, which is a method of valuing Celularity by comparing valuation metrics of similar companies.

Celularity is currently under evaluation in gross profit category among its peers.

Celularity ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Celularity's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Celularity's managers, analysts, and investors.

Environmental

Governance

Social

Celularity Fundamentals

	Return On Equity	-1.54
	Return On Asset	-0.15
	Profit Margin	(2.64) %
	Operating Margin	(0.84) %
	Current Valuation	127.62 M
	Shares Outstanding	22.01 M
	Shares Owned By Insiders	50.39 %
	Shares Owned By Institutions	14.84 %
	Number Of Shares Shorted	743.72 K
	Price To Earning	3.08 X
	Price To Book	2.18 X
	Price To Sales	1.42 X
	Revenue	22.77 M
	Gross Profit	(1.69 M)
	EBITDA	(35.91 M)
	Net Income	(196.29 M)
	Cash And Equivalents	42.65 M
	Cash Per Share	0.29 X
	Total Debt	39.24 M
	Debt To Equity	0.41 %
	Current Ratio	0.91 X
	Book Value Per Share	1.27 X
	Cash Flow From Operations	(38.69 M)
	Short Ratio	18.95 X
	Earnings Per Share	(104.78) X
	Target Price	2.5
	Number Of Employees	120
	Beta	0.51
	Market Capitalization	60.73 M
	Total Asset	143.89 M
	Retained Earnings	(841.79 M)
	Working Capital	(47.51 M)
	Net Asset	143.89 M

About Celularity Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Celularity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celularity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celularity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC